SCHEMBL6173480

SCHEMBL6173480

CC(c1ccnc(C(=O)O)c1)C1NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 9/20 0.41
PDE2A O00408 10/20 0.36
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174605 0.89 IGF1R (0.42) IGF1RPDE2A
SCHEMBL6173860 0.88 IGF1R (0.40) IGF1RPDE2A
SCHEMBL6175882 0.87 PDE2A (0.39) IGF1RPDE2A
SCHEMBL6174049 0.86 IGF1R (0.46) IGF1RLMNA
SCHEMBL6171919 0.85 IGF1R (0.41) IGF1RPDE2ALMNA
SCHEMBL6177038 0.85 LMNA (0.42) PDE2ALMNA
SCHEMBL6174695 0.84 LMNA (0.39) IGF1RPDE2ALMNA
SCHEMBL6173932 0.84 IGF1R (0.40) IGF1RLMNA
SCHEMBL6177806 0.84 IGF1R (0.43) IGF1RPDE2A
SCHEMBL6174744 0.83 IGF1R (0.41) IGF1RLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed